newsfilter
← Latest News
GlobeNewswire·

Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions,